<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">91318</article-id><article-id pub-id-type="doi">10.7554/eLife.91318</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.91318.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Class A scavenger receptor MARCO negatively regulates Ace expression and aldosterone production</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Conan JO</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7419-4448</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ratti</surname><given-names>Giorgio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9938-2752</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Veida-Silva</surname><given-names>Hellen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Haberman</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sweeney</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Gordon</surname><given-names>Siamon</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Domingos</surname><given-names>Ana I</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7938-4814</contrib-id><email>ana.domingos@dpag.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Department of Physiology, Anatomy, &amp; Genetics, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/036rp1748</institution-id><institution>Internal Medicine Department, University of Sao Paulo</institution></institution-wrap><addr-line><named-content content-type="city">São Paulo</named-content></addr-line><country>Brazil</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00d80zx46</institution-id><institution>College of Medicine, Chang Gung University</institution></institution-wrap><addr-line><named-content content-type="city">Taoyuan</named-content></addr-line><country>Taiwan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Sir William Dunn School of Pathology, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ginhoux</surname><given-names>Florent</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vmmgg57</institution-id><institution>Singapore Immunology Network</institution></institution-wrap><country>Singapore</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Takayanagi</surname><given-names>Hiroshi</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>The University of Tokyo</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>12</month><year>2025</year></pub-date><volume>12</volume><elocation-id>RP91318</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-09-02"><day>02</day><month>09</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-09-28"><day>28</day><month>09</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.26.559578"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-13"><day>13</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.91318.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-10"><day>10</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.91318.2"/></event></pub-history><permissions><copyright-statement>© 2023, O'Brien et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>O'Brien et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-91318-v1.pdf"/><abstract><p>Aldosterone is a potent cholesterol-derived steroid hormone that plays a major role in controlling blood pressure via regulation of blood volume. The release of aldosterone is typically controlled by the renin–angiotensin–aldosterone system, situated in the adrenal glands, kidneys, and lungs. Here, we reveal that the class A scavenger receptor MARCO, expressed on alveolar macrophages, negatively regulates aldosterone production and suppresses angiotensin-converting enzyme (Ace) expression in the lungs of male mice. Collectively, our findings suggest alveolar macrophages as additional players in the renin–angiotensin–aldosterone system and introduce a novel example of interplay between the immune and endocrine systems.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>macrophages</kwd><kwd>endocrine</kwd><kwd>RAAS</kwd><kwd>aldosterone</kwd><kwd>adrenal</kwd><kwd>lung</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02wdwnk04</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>FS/19/61/34900</award-id><principal-award-recipient><name><surname>O'Brien</surname><given-names>Conan JO</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>208576/Z/17/Z</award-id><principal-award-recipient><name><surname>Domingos</surname><given-names>Ana I</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0472cxd90</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>2017 10 COG 771431</award-id><principal-award-recipient><name><surname>Domingos</surname><given-names>Ana I</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04x4v8p40</institution-id><institution>Pfizer</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Domingos</surname><given-names>Ana I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Loss of class A scavenger receptor MARCO results in elevated lung Ace expression and elevated plasma aldosterone concentrations in male mice, demonstrating an endocrine function of this immune scavenger receptor.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The scavenger receptor MARCO (macrophage receptor with collagenous structure), a class A scavenger receptor, is primarily expressed on macrophages including tumour-associated macrophages and lung macrophages (<xref ref-type="bibr" rid="bib29">Shi et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">van der Laan et al., 1997</xref>). MARCO, upregulated in response to pathogenic challenge (<xref ref-type="bibr" rid="bib35">van der Laan et al., 1997</xref>), has been implicated in defence against pathogens in the lung (<xref ref-type="bibr" rid="bib1">Arredouani et al., 2004</xref>), phagocytosis and clearance of tumour cells (<xref ref-type="bibr" rid="bib36">Xing et al., 2021</xref>), internalisation of exosomes (<xref ref-type="bibr" rid="bib14">Kanno et al., 2020</xref>), and has been touted as a potential target in anti-cancer immunotherapy (<xref ref-type="bibr" rid="bib6">Eisinger et al., 2020</xref>). The class A scavenger receptors have a broad ligand specificity and similar domain structures, comprising a cytoplasmic tail, transmembrane region, spacer region, α helical coiled domain, collagenous domain, and a C-terminal cysteine-rich domain (<xref ref-type="bibr" rid="bib21">Plüddemann et al., 2007</xref>). Known endogenous ligands for the receptor include, like other class A receptors, modified forms of low-density lipoprotein (<xref ref-type="bibr" rid="bib21">Plüddemann et al., 2007</xref>) indicating that this receptor could be involved in the modulation of cholesterol availability. Scavenger receptors have previously been implicated in corticosteroid output from the adrenal gland. Specifically, Scavenger Receptor BI (SR-BI) was shown to regulate glucocorticoid responses via binding of serum cholesterol, the necessary substrate for adrenal corticosteroids (<xref ref-type="bibr" rid="bib23">Rigotti et al., 1997</xref>; <xref ref-type="bibr" rid="bib32">Temel et al., 1997</xref>; <xref ref-type="bibr" rid="bib10">Hoekstra et al., 2009</xref>; <xref ref-type="bibr" rid="bib13">Ito et al., 2020</xref>). Aldosterone, the other major adrenal cortex-derived corticosteroid, is known to be regulated by the renin–angiotensin–aldosterone system, which is situated in the adrenals, lung, and kidney (<xref ref-type="bibr" rid="bib25">Santos et al., 2019</xref>). While a role for scavenger receptors in regulating glucocorticoid responses has been demonstrated, the role of macrophage-expressed scavenger receptors in the regulation of adrenal corticosteroid output at steady state has not yet been explored.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>It is known that statins, cholesterol-lowering drugs have been shown to reduce aldosterone levels in humans (<xref ref-type="bibr" rid="bib2">Baudrand et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Hornik et al., 2020</xref>). Moreover, in vitro studies have demonstrated that cholesterol supplementation boosts the production of aldosterone from cultured cells (<xref ref-type="bibr" rid="bib30">Simpson et al., 1989</xref>; <xref ref-type="bibr" rid="bib3">Cherradi et al., 2001</xref>; <xref ref-type="bibr" rid="bib15">Kopprasch et al., 2009</xref>). Given that the adrenal-derived mouse corticosteroids, most notably corticosterone and aldosterone, derive from cholesterol as the common precursor (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), we hypothesised that cholesterol binding scavenger receptors could modulate adrenal corticosteroid output by regulating the availability of cholesterol that could feed into the steroid hormone biosynthetic pathway. To test this hypothesis, we measured the concentrations of aldosterone and corticosterone in the plasma of <italic>Marco<sup>−/−</sup></italic> and wild-type (WT) mice. We found that male <italic>Marco<sup>−/−</sup></italic> mice had significantly elevated levels of plasma aldosterone relative to WT mice (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In contrast, plasma corticosterone levels were not significantly altered in male mice lacking Marco (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Marco-deficient female mice did not have altered levels of aldosterone relative to WT, but plasma corticosterone was increased relative to WT counterparts (<xref ref-type="fig" rid="fig1">Figure 1D, E</xref>). We observed that the adrenal glands from Marco-deficient male mice were significantly lighter than WT controls in male but not female mice (<xref ref-type="fig" rid="fig1">Figure 1F, G</xref>). To establish whether cholesterol could explain the elevated plasma aldosterone we observe in Marco-deficient male mice, we measured the levels of total serum cholesterol and intra-adrenal cholesterol in males. We found that <italic>Marco<sup>−/−</sup></italic> mice had reduced serum cholesterol relative to WT controls (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), while the normalised levels of intra-adrenal cholesterol were similar between both mouse strains (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). Taken collectively, these findings suggest that, while Marco-deficient male mice have elevated plasma aldosterone concentrations, this is not dependent on systemic or intra-adrenal cholesterol availability. For the purposes of this paper, we focused on the phenotype evident in male mice, namely the increase in plasma aldosterone concentrations.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Marco-deficient mice have elevated aldosterone and reduced serum cholesterol.</title><p>(<bold>A</bold>) Schematic depicting the murine adrenal corticosteroid biosynthetic pathway. Plasma aldosterone and corticosterone concentrations from wild-type (WT) and Marco-deficient male (<bold>B, C</bold>) and female (<bold>D, E</bold>) mice as measured by ELISA. (<bold>F, G</bold>) Weights of both adrenal glands from WT or Marco-deficient male and female mice. Plasma total cholesterol levels (<bold>H</bold>) and relative intra-adrenal cholesterol levels, normalised to adrenal weight (<bold>I</bold>), in WT and Marco-deficient male mice. Data in B–H were analysed by two-tailed unpaired Student’s <italic>t</italic>-test and are shown as average ± SEM. *p &lt; 0.05, **p &lt; 0.01, ****p &lt; 0.0001, ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91318-fig1-v1.tif"/></fig><p>We next hypothesised that adrenal gland-derived <italic>Marco</italic> could play a role in modulating aldosterone output. Analysis of publicly available single-cell sequencing data from murine adrenal glands shows that adrenals do contain a substantial population of macrophages expressing <italic>Ptprc</italic> (CD45), <italic>Adgre1</italic> (F4/80), and <italic>Cd68</italic> (CD68). However, we did not detect Marco expression in this cluster of cells, nor any other cluster identified in our analyses (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This finding was corroborated by immunostaining of male murine adrenal glands, which showed CD68<sup>+</sup> macrophages in the adrenal zona fasciculata and zona glomerulosa that did not stain positively for MARCO (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Given that the lung is another site in the RAAS axis, we postulated that Marco-expressing cells in the lung could be involved in mediating the aldosterone phenotype we observed in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. Indeed, single-cell RNA-seq analysis of the murine lung shows that <italic>Ptprc</italic> (CD45), <italic>Adgre1</italic> (F4/80), and <italic>Cd68</italic> (CD68) expressing cells (alveolar macrophages) also express <italic>Marco</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), a finding corroborated by immunostaining in the lung (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). To further validate our single-cell sequencing and immunofluorescence data, we carried out qPCR for <italic>Marco</italic> in the lungs and adrenal glands from male WT and <italic>Marco<sup>−/−</sup></italic> mice, which further demonstrated that the lung is the primary site of Marco expression in the RAAS (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Marco is expressed in the lung and not adrenal glands.</title><p>(<bold>A</bold>) Single-cell RNA-seq data plots from PMID 33571131 representing mRNA expression of Ptprc (CD45), Adgre1 (F4/80), Cd68, and Marco, in male murine adrenal glands. (<bold>B</bold>) Representative image showing a central cryosection of the male murine adrenal gland from a C57bl/6 mouse stained against CD68 (green) Marco (magenta), and DAPI (cyan). (<bold>C</bold>) Single-cell RNA-seq data plots from PMID 30283141 representing mRNA expression of Ptprc (CD45), Adgre1 (F4/80), Cd68, and Marco, in the male murine lung. (<bold>D</bold>) Representative image showing a cryosection of the male murine lung from a hCD68-GFP reporter mouse stained against GFP (green) Marco (magenta), and DAPI (cyan). (<bold>E</bold>) qPCR data showing the relative gene expression data for <italic>Marco</italic> in the indicated tissues. M = medulla, ZF = zona fasciculata, ZG = zona glomerulosa. Data in E were analysed by two-tailed unpaired Student’s <italic>t</italic>-test and are shown as average ± SEM. ****p &lt; 0.0001, ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91318-fig2-v1.tif"/></fig><p>Aldosterone is a potent blood pressure-regulating hormone, the dysregulation of which can cause severe hypertension and increased cardiovascular risk. It therefore follows that its production is tightly regulated. Aldosterone biosynthesis is fundamentally regulated intra-adrenally by cytochrome P450 family members in the corticosteroid biosynthetic pathway (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We therefore tested whether altered expression of enzymes in this pathway could explain the hyperaldosteronism observed in Marco-deficient mice. <italic>Marco<sup>−/−</sup></italic> male and female mice showed similar expression of aldosterone biosynthetic enzymes (<italic>Star</italic>, <italic>Cyp11a1</italic>, <italic>Hsd3b1</italic>, <italic>Cyp11b1</italic>, and <italic>Cyp11b2</italic>) as WT mice (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). While <italic>Cyp11b2</italic> (aldosterone synthase) is only expressed in the adrenal zona glomerulosa, other biosynthetic enzymes essential for aldosterone production are expressed in the zona fasciculata.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Marco-mediated elevation of aldosterone is not explained by upregulation of adrenal biosynthetic enzymes, the zona fasciculata, or renin.</title><p>qPCR data reporting the expression of adrenal corticosteroid biosynthetic enzymes between wild-type (WT) and Marco-deficient male mice in male (<bold>A</bold>) and female (<bold>B</bold>) mice. (<bold>C</bold>) A schematic illustrating that pituitary-derived adrenocorticotropic hormone (ACTH) stimulates the upregulation of Cyp11b1 from the zona fasciculata (ZF) and the dexamethasone-mediated suppression of this effect. (<bold>D</bold>) A bar graph showing the plasma aldosterone concentrations of Marco-deficient mice treated with vehicle or dexamethasone-supplemented drinking water for 14 days. (<bold>E</bold>) A bar graph showing the plasma renin activity of WT and Marco-deficient mice at steady state. All data were analysed by two-tailed unpaired Student’s <italic>t</italic>-test and are shown as average ± SEM. ns p &gt; 0.05. ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91318-fig3-v1.tif"/></fig><p>CYP11B1 catalyses the conversion of 11-deoxycorticosterone to corticosterone. Corticosterone can be catalysed to aldosterone by CYP11B2. In this sense, the route via CYP11B1 is a bona fide route for the generation of aldosterone, as evidenced by the fact that <italic>Cyp11b1</italic> deletion in mice results in a significant reduction in aldosterone production (<xref ref-type="bibr" rid="bib17">Mullins et al., 2009</xref>). This route is one that is suppressible via the suppressive action of dexamethasone on ACTH and <italic>Cyp11b1</italic> expression. Moreover, ACTH is a known stimulator of aldosterone (<xref ref-type="bibr" rid="bib27">Seely et al., 1989</xref>; <xref ref-type="bibr" rid="bib5">Daidoh et al., 1995</xref>). Dexamethasone-mediated suppression of the zona fasciculata (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; <xref ref-type="bibr" rid="bib8">Finco et al., 2018</xref>) was used to test whether the elevated aldosterone phenotype was zona fasciculata-dependent. Marco-deficient mice fed dexamethasone-supplemented drinking water had plasma aldosterone concentrations comparable to vehicle-treated mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), indicating zona fasciculata activity does not contribute to elevated aldosterone levels in <italic>Marco<sup>−/−</sup></italic> mice. Taken collectively, these findings indicate that elevated aldosterone observed in Marco-deficient mice arises extra-adrenally and can therefore be considered a form of secondary hyperaldosteronism. Kidney-derived renin is the initiating hormone in the enzymatic cascade that generates Angiotensin II, a potent stimulator of adrenal aldosterone production. We therefore compared plasma renin activity between male WT and <italic>Marco<sup>−/−</sup></italic> mice, finding no significant differences between the two strains (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><p>Next, we investigated whether lung-derived angiotensin-converting enzyme (<italic>Ace</italic>) could explain the elevated aldosterone levels observed in <italic>Marco<sup>−/−</sup></italic> mice. ACE in the lung catalyses the conversion of Angiotensin I to the aldosterone-stimulating peptide Angiotensin II. We carried out a qPCR test for <italic>Ace</italic> in the lungs of WT and <italic>Marco<sup>−/−</sup></italic> mice in both sexes, finding that Marco-deficient male animals had elevated levels of lung <italic>Ace</italic> relative to WT controls in male mice only (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Immunofluorescent staining of WT and <italic>Marco<sup>−/−</sup></italic> lungs revealed a substantially higher level of ACE protein in Marco-deficient male mice, while myeloid presence, as measured by CD68 staining, remained unchanged (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). While low levels of ACE expression could be detected in CD68<sup>+</sup> cells (data not shown), the vast majority of ACE was outside of monocytes and macrophages. We used image analysis software to quantify these changes, finding that ACE median fluorescence intensity (MFI) was significantly increased in male Marco-deficient lungs, while CD68<sup>+</sup> myeloid cells were present in WT and knock-out animals at similar levels (<xref ref-type="fig" rid="fig4">Figure 4C, D</xref>). Myeloid cell numbers and lung ACE expression were similar in WT and Marco-deficient female lungs (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>). We also measured the levels of plasma potassium and sodium levels in male and female WT and Marco-deficient animals, but observed no differences between the genotypes (<xref ref-type="fig" rid="fig4">Figure 4G–J</xref>). Since aldosterone is a known regulator of blood pressure via regulation of blood fluid balance, we also measured blood pressure using the tail-cuff method. We observed that Marco-deficient male mice had marginally reduced diastolic blood pressures, but systolic and mean blood pressure were no different between the two strains (<xref ref-type="fig" rid="fig4">Figure 4K–M</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Marco-deficient mice have enhanced expression of Ace in the lung.</title><p>(<bold>A</bold>) qPCR data reporting the expression of angiotensin-converting enzyme (<italic>Ace</italic>) in the lungs of wild-type (WT) and Marco-deficient male and female mice. (<bold>B</bold>) Representative images showing a cryosection of WT and Marco-deficient male murine lungs stained against ACE (green) CD68 (magenta), MARCO (yellow) and DAPI (blue). Quantitation of DAPI-normalised ACE median fluorescence intensity (MFI) (<bold>C</bold>) and CD68<sup>+</sup> myeloid cell presence in the lungs of WT and Marco-deficient male and female mice (<bold>C–F</bold>). Plasma sodium and potassium levels in male and female mice (<bold>G–J</bold>). Systolic, diastolic, and mean blood pressure measurements in male mice of the indicated genotypes (<bold>K–M</bold>). Data in (<bold>A</bold>), (<bold>C–M</bold>), were analysed by two-tailed unpaired Student’s <italic>t</italic>-test and are shown as average ± SEM. *p &lt; 0.05, ***p &lt; 0.001, ns = not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91318-fig4-v1.tif"/></fig><p>We then turned back to analysis of single-cell RNA-seq data to identify the cells in the lung that could be mediating this effect. In the lung, unsupervised cluster analysis revealed a total of 12 cell clusters with distinct gene expression signatures (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We determined the identity of each cell cluster based on the expression of established cell type-specific marker genes, aided by the marker genes identified and outlined in <xref ref-type="fig" rid="fig5">Figure 5B</xref>. We next used dot plots to visualise expression of <italic>Marco</italic> and <italic>Ace</italic> across the different cell clusters. We observed notable <italic>Marco</italic> expression only in alveolar macrophages amongst the different cell clusters (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). <italic>Ace</italic> was shown to be primarily expressed by lung endothelial clusters 1 and 2 (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), in agreement with what is known about lung <italic>Ace</italic> expression. To test whether alveolar macrophages are capable of suppressing endothelial cell <italic>Ace</italic> expression, we co-cultured the MPI alveolar macrophage cell line (<xref ref-type="bibr" rid="bib7">Fejer et al., 2013</xref>), with or without deletion of Marco, with HUVECs endothelial cells for 24 hr, and measured <italic>Ace</italic> expression via qPCR. We observed an increase in <italic>Ace</italic> expression in the Marco-deficient MPI co-cocultures but not WT, though this did not reach statistical significance. Taken collectively, these data suggest a model whereby Marco-expressing alveolar macrophages may, in responses to an as-of-yet unidentified factor, inhibit <italic>Ace</italic> expression at the gene and protein level, and thereby negatively regulate the cleavage of Angiotensin I to form Angiotensin II, and thereby aldosterone production (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>A proposed model for macrophage-mediated regulation of lung Ace expression.</title><p>(<bold>A</bold>) Single-cell RNA-seq UMAP plot depicting the cell types present in the male murine lung. (<bold>B</bold>) Marker heatmap showing the top three gene markers for each cell cluster in (<bold>A</bold>). (<bold>C</bold>) A dot plot showing the gene expression levels of Marco and Ace in the different cell clusters of the male murine lung. (<bold>D</bold>) qPCR data showing the relative expression levels of Ace in co-coltures contraining HUVEC cells with Marco sufficient or deficient MPI macrophages. (<bold>E</bold>) A schematic, generated using <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/fhfe2nn">BioRender</ext-link>, showing the working model by which Marco+ alveolar macrophages regulate aldosterone output from the adrenal gland. Data in (<bold>D</bold>) were analysed by two-tailed unpaired Student’s <italic>t</italic>-test and are shown as average ± SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91318-fig5-v1.tif"/></fig><p>In conclusion, we hereby demonstrate that Marco is a negative regulator of aldosterone production, associated with a suppression of angiotensin-converting enzyme expression in the lungs of male mice. We propose a model in which extra-adrenal Marco expressing alveolar macrophages, through tissue crosstalk with lung endothelial cells, actively inhibit Ace expression and thereby inhibit the production of aldosterone from the adrenal glands.</p></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Multiple studies over preceding decades have shown that macrophages are much more than simply immune and inflammatory cells. Macrophages have been shown to mediate a wide variety of physiological functions and support homeostasis in virtually every tissue they are found (<xref ref-type="bibr" rid="bib33">Theurl et al., 2016</xref>; <xref ref-type="bibr" rid="bib4">Cox et al., 2021</xref>; <xref ref-type="bibr" rid="bib16">Muller et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Hulsmans et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Schafer et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Pirzgalska et al., 2017</xref>). Our original hypothesis centred on the regulation of corticosteroid output via modulation of cholesterol availability. While we ended up disproving this hypothesis, we did provide a novel example of the non-immune functions of tissue macrophages. It was recently shown that tissue-infiltrating macrophages cause neuronal cell death and effective denervation, which disrupts normal melatonin secretion in a model of cardiovascular disease (<xref ref-type="bibr" rid="bib37">Ziegler et al., 2023</xref>). To our knowledge, ours is the first study to report that macrophages are involved in the regulation of hormonal output in vivo at steady state. It is known that immunosuppressants such as cyclosporine can increase blood pressure (<xref ref-type="bibr" rid="bib24">Robert et al., 2010</xref>) yet the mechanism remains incompletely understood. This observation is consistent with our data showing macrophage-mediated negative regulation of the blood pressure-controlling hormone aldosterone. Additionally, the fact that higher ACE/ACE2 ratios have been linked to hypertension and worse outcomes in Covid-19 (<xref ref-type="bibr" rid="bib18">Pagliaro and Penna, 2020</xref>) could implicate MARCO in the susceptibility to severe disease.</p><p>Secondary aldosteronism (SA) is distinguished from primary aldosteronism through renin – SA is characterised by high aldosterone and high or non-suppressed renin levels (<xref ref-type="bibr" rid="bib22">Pócsai et al., 2021</xref>). By this definition, Marco-deficient mice exhibit SA, due to their high aldosterone and normal renin levels. SA is also defined as elevated aldosterone that originates outside of the adrenal gland – in this case from ACE in the lung. This finding raises the intriguing possibility that aldosteronism could be triggered or aggravated by MARCO-binding ligands. The fact that blood pressure and plasma electrolytes are not substantially modulated by Marco deletion, despite elevation in plasma aldosterone concentrations, indicates that this mechanism has not evolved to regulate systemic physiology. However, ACE and Angiotensin II are pleiotropic molecules. In addition to their physiological roles, they are also exhibit immunomodulatory functions. In vitro, lipopolysaccharide (LPS) treatment of the HUVECs endothelial cell line or human primary endothelial cells causes a reduction in ACE activity, mRNA and protein levels. Similarly, ACE expression in human lung tissue is reduced in sepsis patients relative to control tissues (<xref ref-type="bibr" rid="bib9">Hermanns et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Takei et al., 2019</xref>). Supernatant from LPS or TNFα-treated endothelial cells shows a high proportion of ACE<sup>+</sup> endothelial microparticles (EMPs). ACE<sup>+</sup> EMPs are also increased in plasma of mice undergoing experimental lung injury and in human septic patients (<xref ref-type="bibr" rid="bib31">Takei et al., 2019</xref>), indicating shedding of lung endothelial ACE in the context of inflammation. Ace and AngII have been shown to enhance inflammation in a variety of contexts. It may therefore be that Marco-expressing alveolar macrophages exert an immune-modulatory function within the murine lung via controlling tissue <italic>Ace</italic> expression. Alveolar macrophages, which use MARCO to bind and uptake bacteria (<xref ref-type="bibr" rid="bib19">Palecanda et al., 1999</xref>), could serve to enhance lung immunity in a pathogen and ACE-dependent manner. Pharmacologic ACE inhibition was previously shown to dampen pro-inflammatory immune cell inflammation in radiation-induced pneumonitis (<xref ref-type="bibr" rid="bib28">Sharma et al., 2022</xref>). Future experiments could therefore explore whether Marco regulates lung tissue Ace expression in the context of inflammation and/or pathogenic challenge. While acute increases of plasma aldosterone have varying effects on endothelial function in humans and animal models, chronic (i.e. genetic) elevations of plasma aldosterone are virtually universally associated with endothelial dysfunction (<xref ref-type="bibr" rid="bib34">Toda et al., 2013</xref>). This is frequently characterised by reduced endothelial NOS activity from, and acetylcholine action on, endothelial cells (<xref ref-type="bibr" rid="bib34">Toda et al., 2013</xref>). It would therefore be logical to test whether vascular dysfunction is present in the endothelia of Marco-deficient mice relative to WT mice.</p><p>While the data presented here indicate that Marco deletion is a positive regulator of aldosterone and lung Ace expression, important questions remain to be answered, such as the precise mechanism by which Marco-expressing alveolar macrophages suppress Ace expression, and the ligand(s) responsible for stimulating this effect via the receptor. Additionally, the mechanisms mediating the sex differences observed here remain unexplored. Our findings nevertheless introduce a novel immune paradigm: the renin–angiotensin–aldosterone system.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Mice</title><p>C57BL/6J, Marco<sup>−/−</sup>, and hCD68<sup>GFP/GFP</sup> mice were bred and housed in individually ventilated cages in specific pathogen-free conditions at the University of Oxford. All experiments on mice were conducted according to institutional, national, and European animal regulations. Animal protocols were approved by the animal welfare and ethics review board of the Department of Physiology, Anatomy, and Genetics at the University of Oxford.</p></sec><sec id="s4-2"><title>Tissue collection</title><p>All tissues were collected from 8- to 11-week-old male mice that were culled between 0930 and 1100. Mice were euthanised by intraperitoneal injection of 10 μl/g 200 mg/ml Pentoject (pentobarbital sodium; Animalcare). Following cessation of the pedal motor reflex, a sample of blood was taken from the right atrium prior to perfusion through the left ventricle with 20 ml 1X phosphate-buffered saline (PBS; Sigma-Aldrich). Adrenal glands were dissected, and the peri-adrenal fat removed using a stereomicroscope. Following harvest, adrenal glands and lungs were frozen at –80°C until subsequent molecular analyses or fixed overnight in 4% paraformaldehyde prior to histological analyses. Bloods obtained prior to perfusion were collected into EDTA coated tubes to prevent clotting and centrifuged at 1000 × <italic>g</italic> for 15 min to separate plasma. Plasma samples were frozen at –80°C in 1.5 ml Eppendorf tubes until subsequent analyses.</p></sec><sec id="s4-3"><title>Plasma hormone, cholesterol, renin activity, and electrolyte quantitation</title><p>We measured plasma aldosterone and corticosterone using reverse ELISA kits (Enzo Life Sciences) according to the manufacturer’s instructions. Plasma cholesterol was quantified by colourimetric assay (Cholesterol Quantitation Kit; Sigma-Aldrich) according to the manufacturer’s instructions. Plasma renin activity was measured by fluorometric assay using the Renin Assay Kit (Sigma-Aldrich). Colourimetric and fluorimetric readouts from these assays were attained using a FLUOstar Omega plate reader (BMG Labtech). Plasma electrolytes were outsourced to Pinmoore Animal Laboratory Services Limited (Cheshire, England) and sodium and potassium electrolyte readings were taken using an I-Smart 30 Vet electrolyte analyser (Woodley Equipment).</p></sec><sec id="s4-4"><title>Single-cell sequencing data analysis</title><p>Publicly available single-cell RNA-seq datasets (steady-state adrenal: PMID 33571131, GEO accession number GSE161751; steady-state lung: PMID 30283141, GEO accession number GSE109774) were processed, explored and visualised using Cellenics community instance (<ext-link ext-link-type="uri" xlink:href="https://scp.biomage.net/">https://scp.biomage.net/</ext-link>) hosted by Biomage (<ext-link ext-link-type="uri" xlink:href="https://biomage.net/">https://biomage.net/</ext-link>). For the adrenal dataset, the classifier filter was disabled as the sample had been pre-filtered. The cell size distribution filter was disabled. A mitochondrial content filter was used, with the absolute threshold method used (bin step = 0.05, maximum fraction = 0.1). The number of genes vs UMI filter was used with a linear fit and p-value = 0.0004906771. The doublet filter was used (bin step = 0.05, probability threshold = 0. 8743427). The harmony algorithm was used for data integration (2000 genes, log normalisation). The RPCA method was used for dimensionality reduction (13 principal components). Cells and clusters were visualised using UMAP embedding with the cosine distance metric (minimum distance = 0.2). Louvain clustering was the clustering algorithm used in this analysis (resolution = 0.6). For the lung dataset, the classifier filter was disabled as the sample had been pre-filtered. A cell size distribution filter was utilised with binStep = 200 and minimum cell size = 1669. A mitochondrial content filter was used, with the absolute threshold method used, bin step = 0.3, maximum fraction = 0. The number of genes vs UMI filter was used with a linear fit and p-value = 0.001. The doublet filter was used with bin step = 0.02 and probability threshold = 0.7616616. The harmony algorithm was used for data integration (2000 genes, log normalisation). The RPCA method was used for dimensionality reduction (24 principal components). Cells and clusters were visualised using UMAP embedding with the cosine distance metric (minimum distance = 0.3). Louvain clustering was the clustering algorithm used in this analysis (resolution = 0.8).</p></sec><sec id="s4-5"><title>Cryo-sectioning and antibody staining</title><p>Prior to tissue embedding, adrenal glands were cryoprotected in 30% sucrose solution (in PBS) overnight. Cryoprotected adrenal glands were embedded in OCT embedding medium (Thermo Fisher Scientific) and snap frozen in liquid nitrogen. 15 µm sections were cut from embedded tissues using a Leica cryostat and mounted onto charged microscope slides. Cryosectioned tissue slices were thawed in PBS for 10 min at room temperature, tissue sections were circled using a super PAP pen (Life Technologies), blocked and permeabilised for 1 hr at room temperature in perm/block solution (3% bovine serum albumin, 2% goat serum, 1% Triton X-100, 0.01% NaN<sub>3</sub> in PBS). Slides were stained with CD68-AF647 (clone FA-11, BioLegend), chicken anti-GFP (ab13970, Abcam) with goat anti-chicken AF488 (A11039, Invitrogen), mouse anti-MARCO (ED31, Bio-Rad) with goat anti-mouse AF546 (A-11030, Invitrogen), and rabbit anti-ACE (MA5-32741, Invitrogen) with goat anti-rabbit Alexa Fluor 488 Tyramide Super Boost kit (Invitrogen, B40922). Primary stains were done overnight at 4°C and secondary stains were done for 1 hr at room temperature. The goat anti-rabbit Alexa Fluor 488 Tyramide Super Boost kit was used as per manufacturer’s instructions. DAPI counterstains were done at 1:1000 for 5 min at room temperature. Fluoromount G mounting medium (Invitrogen) was used to mount coverslips to slides which were then sealed with clear nail varnish. Immunofluorescence images were acquired using the Zeiss 880 confocal microscope and images were analysed in FIJI.</p></sec><sec id="s4-6"><title>RT-PCR</title><p>Tissues were homogenised using the Precellys Hard Tissue Grinding Kit (MK28-R; Bertin Technologies). Total RNA from homogenised adrenals or lungs was isolated using RNeasy Plus Micro Kit (QIAGEN, cat# 74034). cDNA was reverse transcribed using SuperScript II (Invitrogen) and random primers (Invitrogen). Quantitative PCR was performed using SYBR Green (Applied Biosystems) in C1000 Touch Thermal Cycler (Bio-Rad). Β-actin was used as the housekeeping gene to normalise samples. We used the following formula to calculate the relative expression levels: RQ = 2<sup>−ΔCt</sup> × 100 = 2<sup>−(Ct gene of interest – Ct β actin)</sup> × 100. The following mouse-specific primers were used. <italic>Star</italic> forward 5′-<named-content content-type="sequence">CAGGGCCAAGAAAACCTACA</named-content>-3′; <italic>Star</italic> reverse 5<named-content content-type="sequence">′-ACGAGCATTTTGAAGCACCT</named-content>-3′; <italic>Cyp11a1</italic> forward 5′-<named-content content-type="sequence">AGGACTTTCCCTGCGCT</named-content>-3′; <italic>Cyp11a1</italic> reverse 5′-<named-content content-type="sequence">GCATCTCGGTAATGTTGG</named-content>-3′; <italic>Hsd3b1</italic> forward 5′-<named-content content-type="sequence">GCGGCTGCTGCACAGGAATAAAG</named-content>-3′; <italic>Hsd3b1</italic> reverse 5′-<named-content content-type="sequence">TCACCAGGCAGCTCCATCCA</named-content>-3′; <italic>Cyp11b1</italic> forward 5′-<named-content content-type="sequence">TCACCATGTGCTGAAATCCTTCCA</named-content>-3′; <italic>Cyp11b1</italic> reverse 5′-<named-content content-type="sequence">GGAAGAGAAGAGAGGGCAATGTGT</named-content>-3′; <italic>Cyp11b2</italic> forward 5′-<named-content content-type="sequence">CAGGGCCAAGAAAACCTACA</named-content>-3′; <italic>Cyp11b2</italic> reverse 5′-<named-content content-type="sequence">ACGAGCATTTTGAAGCACCT</named-content>-3′; <italic>Β-actin</italic> forward 5′-<named-content content-type="sequence">TCATGAAGTGTACGTGGACATCC</named-content>-3′; <italic>Ace</italic> forward 5′- <named-content content-type="sequence">GCTTCCTCTTTCTGCTGCTCTG</named-content>-3′; <italic>Ace</italic> reverse 5′-<named-content content-type="sequence">TGCCCTCTATGGTAATGTTGGT</named-content>-3′; <italic>B-actin</italic> reverse 5′-<named-content content-type="sequence">CCTAGAAGCATTTGCGGTGGACGATG</named-content>-3′.</p></sec><sec id="s4-7"><title>Zona fasciculata suppression model</title><p>Water-soluble dexamethasone (Sigma-Aldrich) was reconstituted in autoclaved deionised water at the concentration of 0.0167 mg/ml as described in <xref ref-type="bibr" rid="bib8">Finco et al., 2018</xref>. Ten-week-old <italic>Marco<sup>−/−</sup></italic> mice were fed dexamethasone-supplemented drinking water for 14 days prior to blood sampling as described above.</p></sec><sec id="s4-8"><title>Digital image analysis</title><p>Quantitation of the area and intensities of immunofluorescent stains was done using FIJI image analysis software. Three cryosections of stained lung tissue (~5 mm<sup>2</sup> tissue acquired per section) were analysed per mouse. CD68<sup>+</sup> cells were segmented using the Otsu thresholding plugin. The parameters were adjusted manually to ensure optimum cell segmentation. DAPI-stained nuclei were segmented using the Otsu thresholding plugin. MFI for ACE was measured via the integrated density of the stain, which was normalised to the area of DAPI staining.</p></sec><sec id="s4-9"><title>Blood pressure readings</title><p>Systolic, diastolic, and mean blood pressures were taken using the CODA high throughput non-invasive blood pressure system (Kent Scientific). Mice were acclimatised to animal holders on three occasions in the week prior to experimental readings.</p></sec><sec id="s4-10"><title>Co-culture</title><p>X63-GMCSF and WT and Marco-deficient MPI cells were a kind gift from Dr Subhankar Mukhopadhyay. Cell identity was confirmed by qPCR and lines tested negative for mycoplasma. 20,000 HUVEC cells were plated with 20,000 WT or Marco-deficient MPI cells in 96 well plates for 24 hr in high glucose DMEM, 10% fetal bovine serum, 1% X63-GM-CSF conditioned media as a source of GM-CSF, 1% penicillin/streptomycin (P/S), and 1X MesoEndo Cell growth medium (all bought from Sigma-Aldrich) and incubated at 37°C, 5% CO<sub>2</sub>. RNA was extracted and qPCRs performed as previously described.</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Results are expressed as the mean ± SEM, as indicated in the figure legends. Statistical significance between two experimental groups was assessed using two-tailed Student’s <italic>t</italic>-test. All statistical analyses were performed in GraphPad Prism 9 (GraphPad, USA) for Mac OS X. All calculated p-values are reported in the figures, denoted by *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ns p &gt; 0.05.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Resources, Funding acquisition, Project administration</p></fn><fn fn-type="con" id="con7"><p>Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments on mice were conducted according to institutional, national, and European animal regulations. All experimental procedures were performed on living animals in accordance with the UK Animals Acts 1986 under the project licence (PPL no. P80EDA9F7) and personal licences granted by the UK Home Office. Animal protocols were approved by the animal welfare and ethics review board of the Department of Physiology, Anatomy, and Genetics at the University of Oxford.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-91318-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>This file contains source data for <xref ref-type="fig" rid="fig1">Figures 1</xref>—<xref ref-type="fig" rid="fig5">5</xref>.</title></caption><media xlink:href="elife-91318-data1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>JP</given-names></name><name><surname>Roeh</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>The neuroendocrine stress response at single-cell resolution reveals adrenal ABCB1 as key regulator of stress adaptation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161751">GSE161751</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><collab>The Tabula Muris Consortium</collab></person-group><year iso-8601-date="2018">2018</year><data-title>Tabula Muris: Transcriptomic characterization of 20 organs and tissues from <italic>Mus musculus</italic> at single cell resolution</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109774">GSE109774</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This research was funded in whole or in part by the BHF graduate studentship FS/19/61/34900, the Wellcome/HHMI International Research Scholar award 208576/Z/17/Z, ERC grant 2017 COG 771431, the Pfizer ASPIRE Obesity award and the Next Iteration of the Type 2 Diabetes Knowledge Portal (2UM1DK105554). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arredouani</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Ning</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Soininen</surname><given-names>R</given-names></name><name><surname>Tryggvason</surname><given-names>K</given-names></name><name><surname>Kobzik</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles</article-title><source>The Journal of Experimental Medicine</source><volume>200</volume><fpage>267</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1084/jem.20040731</pub-id><pub-id pub-id-type="pmid">15263032</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baudrand</surname><given-names>R</given-names></name><name><surname>Pojoga</surname><given-names>LH</given-names></name><name><surname>Vaidya</surname><given-names>A</given-names></name><name><surname>Garza</surname><given-names>AE</given-names></name><name><surname>Vöhringer</surname><given-names>PA</given-names></name><name><surname>Jeunemaitre</surname><given-names>X</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name><name><surname>Yao</surname><given-names>TM</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Adler</surname><given-names>GK</given-names></name><name><surname>Williams</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Statin use and adrenal aldosterone production in hypertensive and diabetic subjects</article-title><source>Circulation</source><volume>132</volume><fpage>1825</fpage><lpage>1833</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.016759</pub-id><pub-id pub-id-type="pmid">26432671</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherradi</surname><given-names>N</given-names></name><name><surname>Bideau</surname><given-names>M</given-names></name><name><surname>Arnaudeau</surname><given-names>S</given-names></name><name><surname>Demaurex</surname><given-names>N</given-names></name><name><surname>James</surname><given-names>RW</given-names></name><name><surname>Azhar</surname><given-names>S</given-names></name><name><surname>Capponi</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I</article-title><source>Endocrinology</source><volume>142</volume><fpage>4540</fpage><lpage>4549</lpage><pub-id pub-id-type="doi">10.1210/endo.142.10.8412</pub-id><pub-id pub-id-type="pmid">11564720</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>N</given-names></name><name><surname>Crozet</surname><given-names>L</given-names></name><name><surname>Holtman</surname><given-names>IR</given-names></name><name><surname>Loyher</surname><given-names>P-L</given-names></name><name><surname>Lazarov</surname><given-names>T</given-names></name><name><surname>White</surname><given-names>JB</given-names></name><name><surname>Mass</surname><given-names>E</given-names></name><name><surname>Stanley</surname><given-names>ER</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Geissmann</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diet-regulated production of PDGFcc by macrophages controls energy storage</article-title><source>Science</source><volume>373</volume><elocation-id>eabe9383</elocation-id><pub-id pub-id-type="doi">10.1126/science.abe9383</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daidoh</surname><given-names>H</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Mune</surname><given-names>T</given-names></name><name><surname>Murayama</surname><given-names>M</given-names></name><name><surname>Hanafusa</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects</article-title><source>Clinical Endocrinology</source><volume>43</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.1995.tb02037.x</pub-id><pub-id pub-id-type="pmid">7586600</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisinger</surname><given-names>S</given-names></name><name><surname>Sarhan</surname><given-names>D</given-names></name><name><surname>Boura</surname><given-names>VF</given-names></name><name><surname>Ibarlucea-Benitez</surname><given-names>I</given-names></name><name><surname>Tyystjärvi</surname><given-names>S</given-names></name><name><surname>Oliynyk</surname><given-names>G</given-names></name><name><surname>Arsenian-Henriksson</surname><given-names>M</given-names></name><name><surname>Lane</surname><given-names>D</given-names></name><name><surname>Wikström</surname><given-names>SL</given-names></name><name><surname>Kiessling</surname><given-names>R</given-names></name><name><surname>Virgilio</surname><given-names>T</given-names></name><name><surname>Gonzalez</surname><given-names>SF</given-names></name><name><surname>Kaczynska</surname><given-names>D</given-names></name><name><surname>Kanatani</surname><given-names>S</given-names></name><name><surname>Daskalaki</surname><given-names>E</given-names></name><name><surname>Wheelock</surname><given-names>CE</given-names></name><name><surname>Sedimbi</surname><given-names>S</given-names></name><name><surname>Chambers</surname><given-names>BJ</given-names></name><name><surname>Ravetch</surname><given-names>JV</given-names></name><name><surname>Karlsson</surname><given-names>MCI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells</article-title><source>PNAS</source><volume>117</volume><fpage>32005</fpage><lpage>32016</lpage><pub-id pub-id-type="doi">10.1073/pnas.2015343117</pub-id><pub-id pub-id-type="pmid">33229588</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fejer</surname><given-names>G</given-names></name><name><surname>Wegner</surname><given-names>MD</given-names></name><name><surname>Györy</surname><given-names>I</given-names></name><name><surname>Cohen</surname><given-names>I</given-names></name><name><surname>Engelhard</surname><given-names>P</given-names></name><name><surname>Voronov</surname><given-names>E</given-names></name><name><surname>Manke</surname><given-names>T</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Dölken</surname><given-names>L</given-names></name><name><surname>Prazeres da Costa</surname><given-names>O</given-names></name><name><surname>Branzk</surname><given-names>N</given-names></name><name><surname>Huber</surname><given-names>M</given-names></name><name><surname>Prasse</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Apte</surname><given-names>RN</given-names></name><name><surname>Galanos</surname><given-names>C</given-names></name><name><surname>Freudenberg</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions</article-title><source>PNAS</source><volume>110</volume><fpage>E2191</fpage><lpage>E2198</lpage><pub-id pub-id-type="doi">10.1073/pnas.1302877110</pub-id><pub-id pub-id-type="pmid">23708119</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finco</surname><given-names>I</given-names></name><name><surname>Lerario</surname><given-names>AM</given-names></name><name><surname>Hammer</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sonic Hedgehog and WNT signaling promote adrenal gland regeneration in male mice</article-title><source>Endocrinology</source><volume>159</volume><fpage>579</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1210/en.2017-03061</pub-id><pub-id pub-id-type="pmid">29211850</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermanns</surname><given-names>MI</given-names></name><name><surname>Müller</surname><given-names>AM</given-names></name><name><surname>Tsokos</surname><given-names>M</given-names></name><name><surname>Kirkpatrick</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells</article-title><source>In Vitro Cellular &amp; Developmental Biology. Animal</source><volume>50</volume><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/s11626-013-9707-0</pub-id><pub-id pub-id-type="pmid">24165975</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoekstra</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Hildebrand</surname><given-names>RB</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Lammers</surname><given-names>B</given-names></name><name><surname>Stitzinger</surname><given-names>M</given-names></name><name><surname>Kuiper</surname><given-names>J</given-names></name><name><surname>Van Berkel</surname><given-names>TJC</given-names></name><name><surname>Van Eck</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production</article-title><source>Journal of Lipid Research</source><volume>50</volume><fpage>1039</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1194/jlr.M800410-JLR200</pub-id><pub-id pub-id-type="pmid">19179307</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornik</surname><given-names>ES</given-names></name><name><surname>Altman-Merino</surname><given-names>AE</given-names></name><name><surname>Koefoed</surname><given-names>AW</given-names></name><name><surname>Meyer</surname><given-names>KM</given-names></name><name><surname>Stone</surname><given-names>IB</given-names></name><name><surname>Green</surname><given-names>JA</given-names></name><name><surname>Williams</surname><given-names>GH</given-names></name><name><surname>Adler</surname><given-names>GK</given-names></name><name><surname>Williams</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A clinical trial to evaluate the effect of statin use on lowering aldosterone levels</article-title><source>BMC Endocrine Disorders</source><volume>20</volume><elocation-id>105</elocation-id><pub-id pub-id-type="doi">10.1186/s12902-020-00587-4</pub-id><pub-id pub-id-type="pmid">32664962</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulsmans</surname><given-names>M</given-names></name><name><surname>Clauss</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Aguirre</surname><given-names>AD</given-names></name><name><surname>King</surname><given-names>KR</given-names></name><name><surname>Hanley</surname><given-names>A</given-names></name><name><surname>Hucker</surname><given-names>WJ</given-names></name><name><surname>Wülfers</surname><given-names>EM</given-names></name><name><surname>Seemann</surname><given-names>G</given-names></name><name><surname>Courties</surname><given-names>G</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Savol</surname><given-names>AJ</given-names></name><name><surname>Sager</surname><given-names>HB</given-names></name><name><surname>Lavine</surname><given-names>KJ</given-names></name><name><surname>Fishbein</surname><given-names>GA</given-names></name><name><surname>Capen</surname><given-names>DE</given-names></name><name><surname>Da Silva</surname><given-names>N</given-names></name><name><surname>Miquerol</surname><given-names>L</given-names></name><name><surname>Wakimoto</surname><given-names>H</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Sadreyev</surname><given-names>RI</given-names></name><name><surname>Naxerova</surname><given-names>K</given-names></name><name><surname>Mitchell</surname><given-names>RN</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Weissleder</surname><given-names>R</given-names></name><name><surname>Swirski</surname><given-names>FK</given-names></name><name><surname>Kohl</surname><given-names>P</given-names></name><name><surname>Vinegoni</surname><given-names>C</given-names></name><name><surname>Milan</surname><given-names>DJ</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Nahrendorf</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Macrophages facilitate electrical conduction in the heart</article-title><source>Cell</source><volume>169</volume><fpage>510</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.03.050</pub-id><pub-id pub-id-type="pmid">28431249</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>D</given-names></name><name><surname>Howatt</surname><given-names>D</given-names></name><name><surname>Daugherty</surname><given-names>A</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Temel</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X-A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SR-BI (Scavenger Receptor BI), Not LDL (Low-Density Lipoprotein) receptor, mediates adrenal stress response-brief report</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>40</volume><fpage>1830</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.120.314506</pub-id><pub-id pub-id-type="pmid">32522007</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanno</surname><given-names>S</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Furuyama</surname><given-names>A</given-names></name><name><surname>Takase</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Fukuta</surname><given-names>M</given-names></name><name><surname>Aoki</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Scavenger receptor MARCO contributes to cellular internalization of exosomes by dynamin-dependent endocytosis and macropinocytosis</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>21795</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-78464-2</pub-id><pub-id pub-id-type="pmid">33311558</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopprasch</surname><given-names>S</given-names></name><name><surname>Pietzsch</surname><given-names>J</given-names></name><name><surname>Ansurudeen</surname><given-names>I</given-names></name><name><surname>Graessler</surname><given-names>J</given-names></name><name><surname>Krug</surname><given-names>AW</given-names></name><name><surname>Ehrhart-Bornstein</surname><given-names>M</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion</article-title><source>The Journal of Endocrinology</source><volume>200</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1677/JOE-08-0293</pub-id><pub-id pub-id-type="pmid">18835979</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>PA</given-names></name><name><surname>Koscsó</surname><given-names>B</given-names></name><name><surname>Rajani</surname><given-names>GM</given-names></name><name><surname>Stevanovic</surname><given-names>K</given-names></name><name><surname>Berres</surname><given-names>M-L</given-names></name><name><surname>Hashimoto</surname><given-names>D</given-names></name><name><surname>Mortha</surname><given-names>A</given-names></name><name><surname>Leboeuf</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X-M</given-names></name><name><surname>Mucida</surname><given-names>D</given-names></name><name><surname>Stanley</surname><given-names>ER</given-names></name><name><surname>Dahan</surname><given-names>S</given-names></name><name><surname>Margolis</surname><given-names>KG</given-names></name><name><surname>Gershon</surname><given-names>MD</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Bogunovic</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility</article-title><source>Cell</source><volume>158</volume><fpage>300</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.04.050</pub-id><pub-id pub-id-type="pmid">25036630</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>LJ</given-names></name><name><surname>Peter</surname><given-names>A</given-names></name><name><surname>Wrobel</surname><given-names>N</given-names></name><name><surname>McNeilly</surname><given-names>JR</given-names></name><name><surname>McNeilly</surname><given-names>AS</given-names></name><name><surname>Al-Dujaili</surname><given-names>EAS</given-names></name><name><surname>Brownstein</surname><given-names>DG</given-names></name><name><surname>Mullins</surname><given-names>JJ</given-names></name><name><surname>Kenyon</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cyp11b1 null mouse, a model of congenital adrenal hyperplasia</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>3925</fpage><lpage>3934</lpage><pub-id pub-id-type="doi">10.1074/jbc.M805081200</pub-id><pub-id pub-id-type="pmid">19029289</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagliaro</surname><given-names>P</given-names></name><name><surname>Penna</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ACE/ACE2 ratio: a key also in 2019 Coronavirus Disease (Covid-19)?</article-title><source>Frontiers in Medicine</source><volume>7</volume><elocation-id>335</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2020.00335</pub-id><pub-id pub-id-type="pmid">32626721</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palecanda</surname><given-names>A</given-names></name><name><surname>Paulauskis</surname><given-names>J</given-names></name><name><surname>Al-Mutairi</surname><given-names>E</given-names></name><name><surname>Imrich</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Tryggvason</surname><given-names>K</given-names></name><name><surname>Koziel</surname><given-names>H</given-names></name><name><surname>Kobzik</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles</article-title><source>The Journal of Experimental Medicine</source><volume>189</volume><fpage>1497</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1084/jem.189.9.1497</pub-id><pub-id pub-id-type="pmid">10224290</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirzgalska</surname><given-names>RM</given-names></name><name><surname>Seixas</surname><given-names>E</given-names></name><name><surname>Seidman</surname><given-names>JS</given-names></name><name><surname>Link</surname><given-names>VM</given-names></name><name><surname>Sánchez</surname><given-names>NM</given-names></name><name><surname>Mahú</surname><given-names>I</given-names></name><name><surname>Mendes</surname><given-names>R</given-names></name><name><surname>Gres</surname><given-names>V</given-names></name><name><surname>Kubasova</surname><given-names>N</given-names></name><name><surname>Morris</surname><given-names>I</given-names></name><name><surname>Arús</surname><given-names>BA</given-names></name><name><surname>Larabee</surname><given-names>CM</given-names></name><name><surname>Vasques</surname><given-names>M</given-names></name><name><surname>Tortosa</surname><given-names>F</given-names></name><name><surname>Sousa</surname><given-names>AL</given-names></name><name><surname>Anandan</surname><given-names>S</given-names></name><name><surname>Tranfield</surname><given-names>E</given-names></name><name><surname>Hahn</surname><given-names>MK</given-names></name><name><surname>Iannacone</surname><given-names>M</given-names></name><name><surname>Spann</surname><given-names>NJ</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Domingos</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine</article-title><source>Nature Medicine</source><volume>23</volume><fpage>1309</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1038/nm.4422</pub-id><pub-id pub-id-type="pmid">29035364</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plüddemann</surname><given-names>A</given-names></name><name><surname>Neyen</surname><given-names>C</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Macrophage scavenger receptors and host-derived ligands</article-title><source>Methods</source><volume>43</volume><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2007.06.004</pub-id><pub-id pub-id-type="pmid">17920517</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pócsai</surname><given-names>K</given-names></name><name><surname>Sumánszki</surname><given-names>C</given-names></name><name><surname>Tőke</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><chapter-title>Secondary aldosteronism</chapter-title><person-group person-group-type="editor"><name><surname>Igaz</surname><given-names>Peter</given-names></name></person-group><source>Practical Clinical Endocrinology</source><publisher-name>Springer Nature</publisher-name><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-62011-0_29</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigotti</surname><given-names>A</given-names></name><name><surname>Trigatti</surname><given-names>BL</given-names></name><name><surname>Penman</surname><given-names>M</given-names></name><name><surname>Rayburn</surname><given-names>H</given-names></name><name><surname>Herz</surname><given-names>J</given-names></name><name><surname>Krieger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism</article-title><source>PNAS</source><volume>94</volume><fpage>12610</fpage><lpage>12615</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.23.12610</pub-id><pub-id pub-id-type="pmid">9356497</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>N</given-names></name><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Wright</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Effect of cyclosporine on blood pressure</article-title><source>The Cochrane Database of Systematic Reviews</source><volume>20</volume><elocation-id>CD007893</elocation-id><pub-id pub-id-type="doi">10.1002/14651858.CD007893.pub2</pub-id><pub-id pub-id-type="pmid">20091657</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>RAS</given-names></name><name><surname>Oudit</surname><given-names>GY</given-names></name><name><surname>Verano-Braga</surname><given-names>T</given-names></name><name><surname>Canta</surname><given-names>G</given-names></name><name><surname>Steckelings</surname><given-names>UM</given-names></name><name><surname>Bader</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The renin-angiotensin system: going beyond the classical paradigms</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>316</volume><fpage>H958</fpage><lpage>H970</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00723.2018</pub-id><pub-id pub-id-type="pmid">30707614</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>DP</given-names></name><name><surname>Lehrman</surname><given-names>EK</given-names></name><name><surname>Kautzman</surname><given-names>AG</given-names></name><name><surname>Koyama</surname><given-names>R</given-names></name><name><surname>Mardinly</surname><given-names>AR</given-names></name><name><surname>Yamasaki</surname><given-names>R</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner</article-title><source>Neuron</source><volume>74</volume><fpage>691</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.026</pub-id><pub-id pub-id-type="pmid">22632727</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seely</surname><given-names>EW</given-names></name><name><surname>Conlin</surname><given-names>PR</given-names></name><name><surname>Brent</surname><given-names>GA</given-names></name><name><surname>Dluhy</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion</article-title><source>The Journal of Clinical Endocrinology and Metabolism</source><volume>69</volume><fpage>1028</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1210/jcem-69-5-1028</pub-id><pub-id pub-id-type="pmid">2551915</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>GP</given-names></name><name><surname>Fish</surname><given-names>BL</given-names></name><name><surname>Frei</surname><given-names>AC</given-names></name><name><surname>Narayanan</surname><given-names>J</given-names></name><name><surname>Gasperetti</surname><given-names>T</given-names></name><name><surname>Scholler</surname><given-names>D</given-names></name><name><surname>Pierce</surname><given-names>L</given-names></name><name><surname>Szalewski</surname><given-names>N</given-names></name><name><surname>Blue</surname><given-names>N</given-names></name><name><surname>Medhora</surname><given-names>M</given-names></name><name><surname>Himburg</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pharmacologic ACE-Inhibition mitigates radiation-induced pneumonitis by suppressing ACE-Expressing lung myeloid cells</article-title><source>International Journal of Radiation Oncology*Biology*Physics</source><volume>113</volume><fpage>177</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2022.01.023</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>B</given-names></name><name><surname>Chu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The scavenger receptor MARCO expressed by tumor-associated macrophages are highly associated with poor pancreatic cancer prognosis</article-title><source>Frontiers in Oncology</source><volume>11</volume><elocation-id>771488</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2021.771488</pub-id><pub-id pub-id-type="pmid">34778091</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>HD</given-names></name><name><surname>Shepherd</surname><given-names>R</given-names></name><name><surname>Shepherd</surname><given-names>J</given-names></name><name><surname>Fraser</surname><given-names>R</given-names></name><name><surname>Lever</surname><given-names>AF</given-names></name><name><surname>Kenyon</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Effects of cholesterol and lipoproteins on aldosterone secretion by bovine zona glomerulosa cells</article-title><source>The Journal of Endocrinology</source><volume>121</volume><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1677/joe.0.1210125</pub-id><pub-id pub-id-type="pmid">2715752</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Kameyama</surname><given-names>Y</given-names></name><name><surname>Sugiura</surname><given-names>H</given-names></name><name><surname>Makiguchi</surname><given-names>T</given-names></name><name><surname>Fujino</surname><given-names>N</given-names></name><name><surname>Koarai</surname><given-names>A</given-names></name><name><surname>Toyama</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Ejima</surname><given-names>Y</given-names></name><name><surname>Kawazoe</surname><given-names>Y</given-names></name><name><surname>Kudo</surname><given-names>D</given-names></name><name><surname>Kushimoto</surname><given-names>S</given-names></name><name><surname>Yamauchi</surname><given-names>M</given-names></name><name><surname>Ichinose</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Increase in circulating ACE-positive endothelial microparticles during acute lung injury</article-title><source>The European Respiratory Journal</source><volume>54</volume><elocation-id>1801188</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.01188-2018</pub-id><pub-id pub-id-type="pmid">31320458</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temel</surname><given-names>RE</given-names></name><name><surname>Trigatti</surname><given-names>B</given-names></name><name><surname>DeMattos</surname><given-names>RB</given-names></name><name><surname>Azhar</surname><given-names>S</given-names></name><name><surname>Krieger</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells</article-title><source>PNAS</source><volume>94</volume><fpage>13600</fpage><lpage>13605</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.25.13600</pub-id><pub-id pub-id-type="pmid">9391072</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theurl</surname><given-names>I</given-names></name><name><surname>Hilgendorf</surname><given-names>I</given-names></name><name><surname>Nairz</surname><given-names>M</given-names></name><name><surname>Tymoszuk</surname><given-names>P</given-names></name><name><surname>Haschka</surname><given-names>D</given-names></name><name><surname>Asshoff</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Gerhardt</surname><given-names>LMS</given-names></name><name><surname>Holderried</surname><given-names>TAW</given-names></name><name><surname>Seifert</surname><given-names>M</given-names></name><name><surname>Sopper</surname><given-names>S</given-names></name><name><surname>Fenn</surname><given-names>AM</given-names></name><name><surname>Anzai</surname><given-names>A</given-names></name><name><surname>Rattik</surname><given-names>S</given-names></name><name><surname>McAlpine</surname><given-names>C</given-names></name><name><surname>Theurl</surname><given-names>M</given-names></name><name><surname>Wieghofer</surname><given-names>P</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name><name><surname>Weber</surname><given-names>GF</given-names></name><name><surname>Harder</surname><given-names>NK</given-names></name><name><surname>Chousterman</surname><given-names>BG</given-names></name><name><surname>Arvedson</surname><given-names>TL</given-names></name><name><surname>McKee</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Lutz</surname><given-names>OMD</given-names></name><name><surname>Rezoagli</surname><given-names>E</given-names></name><name><surname>Babitt</surname><given-names>JL</given-names></name><name><surname>Berra</surname><given-names>L</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Nahrendorf</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>G</given-names></name><name><surname>Weissleder</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>HY</given-names></name><name><surname>Swirski</surname><given-names>FK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver</article-title><source>Nature Medicine</source><volume>22</volume><fpage>945</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1038/nm.4146</pub-id><pub-id pub-id-type="pmid">27428900</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toda</surname><given-names>N</given-names></name><name><surname>Nakanishi</surname><given-names>S</given-names></name><name><surname>Tanabe</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications</article-title><source>British Journal of Pharmacology</source><volume>168</volume><fpage>519</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02194.x</pub-id><pub-id pub-id-type="pmid">23190073</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Laan</surname><given-names>LJ</given-names></name><name><surname>Kangas</surname><given-names>M</given-names></name><name><surname>Döpp</surname><given-names>EA</given-names></name><name><surname>Broug-Holub</surname><given-names>E</given-names></name><name><surname>Elomaa</surname><given-names>O</given-names></name><name><surname>Tryggvason</surname><given-names>K</given-names></name><name><surname>Kraal</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense</article-title><source>Immunology Letters</source><volume>57</volume><fpage>203</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/s0165-2478(97)00077-1</pub-id><pub-id pub-id-type="pmid">9232452</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Ji</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Scavenger receptor MARCO contributes to macrophage phagocytosis and clearance of tumor cells</article-title><source>Experimental Cell Research</source><volume>408</volume><elocation-id>112862</elocation-id><pub-id pub-id-type="doi">10.1016/j.yexcr.2021.112862</pub-id><pub-id pub-id-type="pmid">34626585</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>KA</given-names></name><name><surname>Ahles</surname><given-names>A</given-names></name><name><surname>Dueck</surname><given-names>A</given-names></name><name><surname>Esfandyari</surname><given-names>D</given-names></name><name><surname>Pichler</surname><given-names>P</given-names></name><name><surname>Weber</surname><given-names>K</given-names></name><name><surname>Kotschi</surname><given-names>S</given-names></name><name><surname>Bartelt</surname><given-names>A</given-names></name><name><surname>Sinicina</surname><given-names>I</given-names></name><name><surname>Graw</surname><given-names>M</given-names></name><name><surname>Leonhardt</surname><given-names>H</given-names></name><name><surname>Weckbach</surname><given-names>LT</given-names></name><name><surname>Massberg</surname><given-names>S</given-names></name><name><surname>Schifferer</surname><given-names>M</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name><name><surname>Hoeher</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Ertürk</surname><given-names>A</given-names></name><name><surname>Schiattarella</surname><given-names>GG</given-names></name><name><surname>Sassi</surname><given-names>Y</given-names></name><name><surname>Misgeld</surname><given-names>T</given-names></name><name><surname>Engelhardt</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Immune-mediated denervation of the pineal gland underlies sleep disturbance in cardiac disease</article-title><source>Science</source><volume>381</volume><fpage>285</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1126/science.abn6366</pub-id><pub-id pub-id-type="pmid">37471539</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.91318.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ginhoux</surname><given-names>Florent</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Singapore Immunology Network</institution><country>Singapore</country></aff></contrib></contrib-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group></front-stub><body><p>O'Brien and co-authors provide <bold>important</bold> data demonstrating that tissue-resident macrophages can exert physiological functions and influence endocrine systems. Their model in which AMs negatively regulate aldosterone production via effects exerted in the lung is <bold>solid</bold>. The work will be of broad interest to cell biologists and immunologists.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.91318.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Tissue-resident macrophages are more and more thought to exert key homeostatic functions and contribute to physiological responses. In the report of O'Brien and Colleagues, the idea that the macrophage-expressed scavenger receptor MARCO could regulate adrenal corticosteroid output at steady-state was explored. The authors found that male MARCO-deficient mice exhibited higher plasma aldosterone levels and higher lung ACE expression as compared to wild-type mice, while the availability of cholesterol and the machinery required to produce aldosterone in the adrenal gland were not affected by MARCO deficiency. The authors take these data to conclude that MARCO in alveolar macrophages can negatively regulate ACE expression and aldosterone production at steady-state and that MARCO-deficient mice suffer from a secondary hyperaldosteronism.</p><p>Strengths:</p><p>If properly demonstrated and validated, the fact that tissue-resident macrophages can exert physiological functions and influence endocrine systems would be highly significant and could be amenable to novel therapies.</p><p>Major weakness:</p><p>The comparison between C57BL/6J wild-type mice and knock-out mice for which a precise information about the genetic background and the history of breedings and crossings is lacking can lead to misinterpretations of the results obtained. Hence, MARCO-deficient mice should be compared with true littermate controls.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.91318.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Conan JO</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Ratti</surname><given-names>Giorgio</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Veida-Silva</surname><given-names>Hellen</given-names></name><role specific-use="author">Author</role><aff><institution>University of Sao Paulo, Internal Medicine Department</institution><addr-line><named-content content-type="city">Sao Paulo</named-content></addr-line><country>Brazil</country></aff></contrib><contrib contrib-type="author"><name><surname>Haberman</surname><given-names>Emma</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Sweeney</surname><given-names>Charles</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Gordon</surname><given-names>Siamon</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Domingos</surname><given-names>Ana I</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews</p><p>We again thank the reviewers for their comments and recommendations. In response to the reviewer’s suggestions, we have performed several additional experiments, added additional discussion, and updated our conclusions to reflect the additional work. Specifically, we have performed additional analyses in female WT and Marco-deficient animals, demonstrating that the Marco-associated phonotypes observed in male mice (reduced adrenal weight, increased lung Ace mRNA and protein expression, unchanged expression of adrenal corticosteroid biosynthetic enzymes) are not present in female mice. We also report new data on the physiological consequences of increased aldosterone levels observed in male mice, namely plasma sodium and potassium titres, and blood pressure alterations in WT vs Marco-deficient male mice. In an attempt to address the reviewer’s comments relating to our proposed mechanism on the regulation of lung Ace expression, we additionally performed a co-culture experiment using an alveolar macrophage cell line and an endothelial cell line. In light of the additional evidence presented herein, we have updated our conclusions from this study and changed the title of our work to acknowledge that the mechanism underlying the reported phenotype remains incompletely understood. Specific responses to reviewers can be seen below.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>The investigators sought to determine whether Marco regulates the levels of aldosterone by limiting uptake of its parent molecule cholesterol in the adrenal gland. Instead, they identify an unexpected role for Marco on alveolar macrophages in lowering the levels of angiotensin-converting enzyme in the lung. This suggests an unexpected role of alveolar macrophages and lung ACE in the production of aldosterone.</p><p>Strengths:</p><p>The investigators suggest an unexpected role for ACE in the lung in the regulation of systemic aldosterone levels.</p><p>The investigators suggest important sex-related differences in the regulation of aldosterone by alveolar macrophages and ACE in the lung.</p><p>Studies to exclude a role for Marco in the adrenal gland are strong, suggesting an extra-adrenal source for the excess Marco observed in male Marco knockout mice.</p><p>Weaknesses:</p><p>While the investigators have identified important sex differences in the regulation of extrapulmonary ACE in the regulation of aldosterone levels, the mechanisms underlying these differences are not explored.</p><p>The physiologic impact of the increased aldosterone levels observed in Marco -/- male mice on blood pressure or response to injury is not clear.</p><p>The intracellular signaling mechanism linking lung macrophage levels with the expression of ACE in the lung is not supported by direct evidence.</p><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>Tissue-resident macrophages are more and more thought to exert key homeostatic functions and contribute to physiological responses. In the report of O'Brien and Colleagues, the idea that the macrophage-expressed scavenger receptor MARCO could regulate adrenal corticosteroid output at steady-state was explored. The authors found that male MARCO-deficient mice exhibited higher plasma aldosterone levels and higher lung ACE expression as compared to wild-type mice, while the availability of cholesterol and the machinery required to produce aldosterone in the adrenal gland were not affected by MARCO deficiency. The authors take these data to conclude that MARCO in alveolar macrophages can negatively regulate ACE expression and aldosterone production at steady-state and that MARCO-deficient mice suffer from secondary hyperaldosteronism.</p><p>Strengths:</p><p>If properly demonstrated and validated, the fact that tissue-resident macrophages can exert physiological functions and influence endocrine systems would be highly significant and could be amenable to novel therapies.</p><p>Weaknesses:</p><p>The data provided by the authors currently do not support the major claim of the authors that alveolar macrophages, via MARCO, are involved in the regulation of a hormonal output in vivo at steady-state. At this point, there are two interesting but descriptive observations in male, but not female, MARCO-deficient animals, and overall, the study lacks key controls and validation experiments, as detailed below.</p><p>Major weaknesses:</p><p>(1) According to the reviewer's own experience, the comparison between C57BL/6J wild-type mice and knock-out mice for which precise information about the genetic background and the history of breedings and crossings is lacking, can lead to misinterpretations of the results obtained. Hence, MARCO-deficient mice should be compared with true littermate controls.</p><p>(2) The use of mice globally deficient for MARCO combined with the fact that alveolar macrophages produce high levels of MARCO is not sufficient to prove that the phenotype observed is linked to alveolar macrophage-expressed MARCO (see below for suggestions of experiments).</p><p>(3) If the hypothesis of the authors is correct, then additional read-outs could be performed to reinforce their claims: levels of Angiotensin I would be lower in MARCO-deficient mice, levels of Antiotensin II would be higher in MARCO-deficient mice, Arterial blood pressure would be higher in MARCO-deficient mice, natremia would be higher in MARCO-deficient mice, while kaliemia would be lower in MARCO-deficient mice. In addition, co-culture experiments between MARCO-sufficient or deficient alveolar macrophages and lung endothelial cells, combined with the assessment of ACE expression, would allow the authors to evaluate whether the AM-expressed MARCO can directly regulate ACE expression.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>(1) Corticosterone levels in male Marco -/- mice are not significantly different, but there is (by eye) substantially more variability in the knockout compared to the wild type. A power analysis should be performed to determine the number of mice needed to detect a similar % difference in corticosterone to the difference observed in aldosterone between male Marco knockout and wild-type mice. If necessary the experiments should be repeated with an adequately powered cohort.</p></disp-quote><p>Using a power calculator (<ext-link ext-link-type="uri" xlink:href="https://www.gigacalculator.com/">https://www.gigacalculator.com/</ext-link>) it was determined that our sample size of 13 was one less than sufficient to detect a similar % difference in corticosterone as was detected in corticosterone. We regret that we unable to perform additional measurements as the author suggested in the available timeframe.</p><disp-quote content-type="editor-comment"><p>(2) All of the data throughout the MS (particularly data in the lung) should be presented in male and female mice. For example, the induction of ACE in the lungs of Marco-/- female mice should be absent. Similar concerns relate to the dexamethasone suppression studies. Also would be useful if the single cell data could be examined by sex--should be possible even post hoc using Xist etc.</p></disp-quote><p>Given the limitations outlined in our previous response to reviewers it was not possible to repeat every experiment from the original manuscript. We were able to measure the expression of lung Ace mRNA, ACE protein, adrenal weights, adrenal expression of steroid biosynthetic enzymes, presence of myeloid cells, and levels of serum electrolytes in female animals. These are presented in figures 1G, 3B, 4A, 4E, 4F, 4I, and 4J. We have elected to not present single cell seq data according to sex as it did not indicate substantial differences between males and females in Marco or Ace expression and so does not substantively change our approach.</p><disp-quote content-type="editor-comment"><p>(3) IF is notoriously unreliable in the lung, which has high levels of autofluorescence. This is the only method used to show ACE levels are increased in the absence of Marco. Orthogonal methods (e.g. immunoblots of flow-sorted cells, or ideally CITE-seq that includes both male and female mice) should be used.</p></disp-quote><p>We used negative controls to guide our settings during acquisition of immunofluorescent images. Additionally, we also used qPCR to show an increase in Ace mRNA expression in the lung in addition to the protein level. This data was presented in the original manuscript and is further bolstered by our additional presentation of expression data for Ace mRNA and protein in female animals in this revised manuscript.</p><disp-quote content-type="editor-comment"><p>(4) Given the central importance of ACE staining to the conclusions, validation of the antibody should be included in the supplement.</p></disp-quote><p>We don’t have ACE-deficient mice so cannot do KO validation of the antibody. We did perform secondary stain controls which confirmed the signal observed is primary antibody-derived. Moreover, we specifically chose an anti-ACE antibody (Invitrogen catalogue # MA5-32741) that has undergone advanced verification with the manufacturer. We additionally tested the antibody in the brain and liver and observed no significant levels of staining.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91318-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(5) The link between alveolar macrophage Marco and ACE is poorly explored.</p></disp-quote><p>We carried out a co-culture experiments of alveolar macrophages and endothelial cells and measure ACE/Ace expression as a consequence. This is presented in figure 5D and the discussion.</p><disp-quote content-type="editor-comment"><p>(6) Mechanisms explaining the substantial sex difference in the primary outcome are not explored.</p></disp-quote><p>This is outside the scope if this project, though we would consider exploring such experiments in future studies.</p><disp-quote content-type="editor-comment"><p>(7) Are there physiologic consequences either in homeostasis or under stress to the increased aldosterone (or lung ACE levels) observed in Marco-/- male mice?</p></disp-quote><p>We measured blood electrolytes and blood pressure in Marco-deficient and Marco-sufficient mice. The results from these experiments are presented in 4G-4M.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>Below is a suggestion of important control or validation experiments to be performed in order to support the authors' claims.</p><p>(1) It is imperative to validate that the phenotype observed in MARCO-deficient mice is indeed caused by the deficiency in MARCO. To this end, littermate mice issued from the crossing between heterozygous MARCO +/- mice should be compared to each other. C57BL/6J mice can first be crossed with MARCO-deficient mice in F0, and F1 heterozygous MARCO +/- mice should be crossed together to produce F2 MARCO +/+, MARCO +/- and MARCO -/- littermate mice that can be used for experiments.</p></disp-quote><p>We thank the reviewer for their comments. We recognise the concern of the reviewer but due to limited experimenter availability we are unable to undertake such a breeding programme to address this particular concern.</p><disp-quote content-type="editor-comment"><p>(2) The use of mice in which AM, but not other cells, lack MARCO expression would demonstrate that the effect is indeed linked to AM. To this end, AM-deficient Csf2rb-deficient mice could be adoptively transferred with MARCO-deficient AM. In addition, the phenotype of MARCO-deficient mice should be restored by the adoptive transfer of wild-type, MARCO-expressing AM. Alternatively, bone marrow chimeras in which only the hematopoietic compartment is deficient in MARCO would be another option, albeit less specific for AM.</p></disp-quote><p>We recognise the concern of the reviewer. We carried out a co-culture experiments of alveolar macrophages and endothelial cells and measure ACE/Ace expression as a consequence. This is presented in figure 5D and the implications explored in the discussion.</p><disp-quote content-type="editor-comment"><p>(3) If the hypothesis of the authors is correct, then additional read-outs could be performed to reinforce their claims: levels of Angiotensin I would be lower in MARCO-deficient mice, levels of Antiotensin II would be higher in MARCO-deficient mice, Arterial blood pressure would be higher in MARCO-deficient mice, natremia would be higher in MARCO-deficient mice, while kaliemia would be lower in MARCO-deficient mice. Similar read-outs could also be performed in the models proposed in point 2.</p></disp-quote><p>We measured blood electrolytes and blood pressure in Marco-deficient and Marco-sufficient mice. The results from these experiments are presented in 4G-4M.</p><disp-quote content-type="editor-comment"><p>(4) Co-culture experiments between MARCO-sufficient or deficient alveolar macrophages and lung endothelial cells, combined with the assessment of ACE expression, would allow the authors to evaluate whether the AM-expressed MARCO can directly regulate ACE expression.</p></disp-quote><p>To address this concern we carried out a co-culture experiment as described above.</p></body></sub-article></article>